Table 2 Summary of clinical presentations of stereotactic group
Age/sex | History of hypertension | Co-morbidities | GCS | Hemiparesis | Dysphasia | Prothrombin activity % | Site of hematoma | Size of hematoma CM | Fate | |
|---|---|---|---|---|---|---|---|---|---|---|
1 | 56/female | + | 12 | + | − | 56 | Basal ganglia | 41 | Recovery | |
2 | 70/male | + | Diabetic | 10 | + | − | 62 | Basal ganglia | 37 | Recovery |
3 | 49/male | + | Renal failure | 8 | + | + | 45 | Basal ganglia | 59 | Died |
4 | 61/female | + | Diabetic Hepatitis—C | 9 | + | − | 51 | Basal ganglia | 67 | Died |
5 | 59/male | + | 12 | − | − | 66 | Basal ganglia | 33 | Recovery | |
6 | 63/male | + | 11 | + | − | 59 | Basal ganglia | 38 | Recovery | |
7 | 55/female | − | Hepatitis | 9 | + | + | 37 | Basal ganglia | 68 | Died |
8 | 67/male | + | 12 | + | − | 66 | Basal ganglia | 40 | Recovery | |
9 | 70/female | + | 10 | + | + | 54 | Basal ganglia | 42 | Recovery | |
10 | 54/male | + | Diabetic | 11 | + | − | 56 | Basal ganglia | 35 | Recovery |
11 | 68/male | + | 9 | + | + | 43 | Basal ganglia | 57 | Died | |
12 | 58/female | + | 9 | + | − | 47 | Basal ganglia | 70 | Recovery | |
13 | 65/female | + | 11 | + | − | 56 | Basal ganglia | 44 | Recovery | |
14 | 55/male | − | Diabetic | 9 | + | − | 45 | Basal ganglia | 59 | Recovery |
15 | 70/male | + | Diabetic | 8 | + | + | 30 | Basal ganglia | 69 | Recovery |
16 | 59/male | + | 12 | − | − | 68 | Basal ganglia | 32 | Recovery | |
17 | 53/female | + | Renal failure | 8 | + | + | 51 | Basal ganglia | 66 | Died |
18 | 67/male | + | Diabetic | 11 | + | − | 58 | Basal ganglia | 34 | Recovery |